470 related articles for article (PubMed ID: 24030532)
1. NGF and VEGF effects on retinal ganglion cell fate: new evidence from an animal model of diabetes.
Mantelli F; Lambiase A; Colafrancesco V; Rocco ML; Macchi I; Aloe L
Eur J Ophthalmol; 2014; 24(2):247-53. PubMed ID: 24030532
[TBL] [Abstract][Full Text] [Related]
2. Effect of eye NGF administration on two animal models of retinal ganglion cells degeneration.
Colafrancesco V; Coassin M; Rossi S; Aloe L
Ann Ist Super Sanita; 2011; 47(3):284-9. PubMed ID: 21952154
[TBL] [Abstract][Full Text] [Related]
3. NGF Prevents Loss of TrkA/VEGFR2 Cells, and VEGF Isoform Dysregulation in the Retina of Adult Diabetic Rats.
Fico E; Rosso P; Triaca V; Segatto M; Lambiase A; Tirassa P
Cells; 2022 Oct; 11(20):. PubMed ID: 36291113
[TBL] [Abstract][Full Text] [Related]
4. Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model.
Park HY; Kim JH; Park CK
Am J Pathol; 2014 Jun; 184(6):1752-62. PubMed ID: 24709590
[TBL] [Abstract][Full Text] [Related]
5. Effect of memantine on neuroretinal function and retinal vascular changes of streptozotocin-induced diabetic rats.
Kusari J; Zhou S; Padillo E; Clarke KG; Gil DW
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5152-9. PubMed ID: 17962468
[TBL] [Abstract][Full Text] [Related]
6. The effect of total lignans from Fructus Arctii on Streptozotocin-induced diabetic retinopathy in Wistar rats.
Zhang H; Gao Y; Zhang J; Wang K; Jin T; Wang H; Ruan K; Wu F; Xu Z
J Ethnopharmacol; 2020 Jun; 255():112773. PubMed ID: 32199990
[TBL] [Abstract][Full Text] [Related]
7. Ocular application of nerve growth factor protects degenerating retinal ganglion cells in a rat model of glaucoma.
Colafrancesco V; Parisi V; Sposato V; Rossi S; Russo MA; Coassin M; Lambiase A; Aloe L
J Glaucoma; 2011 Feb; 20(2):100-8. PubMed ID: 20436364
[TBL] [Abstract][Full Text] [Related]
8. Loss-of-function mutation of serine racemase attenuates retinal ganglion cell loss in diabetic mice.
Jiang H; Du J; Song J; Li Y; Wu M; Zhou J; Wu S
Exp Eye Res; 2018 Oct; 175():90-97. PubMed ID: 29913163
[TBL] [Abstract][Full Text] [Related]
9. Effects of alpha-lipoic acid on retinal ganglion cells, retinal thicknesses, and VEGF production in an experimental model of diabetes.
Kan E; Alici Ö; Kan EK; Ayar A
Int Ophthalmol; 2017 Dec; 37(6):1269-1278. PubMed ID: 27848046
[TBL] [Abstract][Full Text] [Related]
10. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
11. Peroxynitrite mediates retinal neurodegeneration by inhibiting nerve growth factor survival signaling in experimental and human diabetes.
Ali TK; Matragoon S; Pillai BA; Liou GI; El-Remessy AB
Diabetes; 2008 Apr; 57(4):889-98. PubMed ID: 18285558
[TBL] [Abstract][Full Text] [Related]
12. Protective Effects of Leukemia Inhibitory Factor on Retinal Vasculature and Cells in Streptozotocin-induced Diabetic Mice.
Yang XF; Huang YX; Lan M; Zhang TR; Zhou J
Chin Med J (Engl); 2018 Jan; 131(1):75-81. PubMed ID: 29271384
[TBL] [Abstract][Full Text] [Related]
13. An endothelin type A receptor antagonist reverses upregulated VEGF and ICAM-1 levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Goto K; Jesmin S; Maeda S; Miyauchi T; Kaji Y; Oshika T; Hori S
Curr Eye Res; 2006 Jan; 31(1):79-89. PubMed ID: 16421022
[TBL] [Abstract][Full Text] [Related]
14. Nerve growth factor helps protect retina in experimental retinal detachment.
Sun X; Xu X; Wang F; Zhang X; Ho PC; Liu H; Qian J; Yu Z; Lu H; Xu W
Ophthalmologica; 2008; 222(1):58-61. PubMed ID: 18097183
[TBL] [Abstract][Full Text] [Related]
15. Epicatechin blocks pro-nerve growth factor (proNGF)-mediated retinal neurodegeneration via inhibition of p75 neurotrophin receptor expression in a rat model of diabetes [corrected].
Al-Gayyar MM; Matragoon S; Pillai BA; Ali TK; Abdelsaid MA; El-Remessy AB
Diabetologia; 2011 Mar; 54(3):669-80. PubMed ID: 21136036
[TBL] [Abstract][Full Text] [Related]
16. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes.
Gilbert RE; Vranes D; Berka JL; Kelly DJ; Cox A; Wu LL; Stacker SA; Cooper ME
Lab Invest; 1998 Aug; 78(8):1017-27. PubMed ID: 9714188
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic induction of heme oxygenase-1 plays a protective role in diabetic retinopathy in rats.
Fan J; Xu G; Jiang T; Qin Y
Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6541-56. PubMed ID: 22661484
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of rosiglitazone on retinal neuronal damage in diabetic rats.
Li P; Xu X; Zheng Z; Zhu B; Shi Y; Liu K
Curr Eye Res; 2011 Jul; 36(7):673-9. PubMed ID: 21599458
[TBL] [Abstract][Full Text] [Related]
19. Effect of endothelin dual receptor antagonist on VEGF levels in streptozotocin-induced diabetic rat retina.
Masuzawa K; Jesmin S; Maeda S; Zaedi S; Shimojo N; Miyauchi T; Goto K
Exp Biol Med (Maywood); 2006 Jun; 231(6):1090-4. PubMed ID: 16741055
[TBL] [Abstract][Full Text] [Related]
20. Intravitreal injection of erythropoietin protects against retinal vascular regression at the early stage of diabetic retinopathy in streptozotocin-induced diabetic rats.
Mitsuhashi J; Morikawa S; Shimizu K; Ezaki T; Yasuda Y; Hori S
Exp Eye Res; 2013 Jan; 106():64-73. PubMed ID: 23178551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
